Clinical Impact of the Size of Drug-Coated Balloon Therapy on Restenosis Rate in Femoropopliteal Lesions

被引:12
|
作者
Kurata, Naoya [1 ]
Iida, Osamu [2 ]
Takahara, Mitusyoshi [3 ]
Asai, Mitsutoshi [2 ]
Masuda, Masaharu [2 ]
Okamoto, Shin [2 ]
Ishihara, Takayuki [2 ]
Nanto, Kiyonori [2 ]
Kanda, Takashi [2 ]
Tsujimura, Takuya [2 ]
Matsuda, Yasuhiro [2 ]
Hata, Yousuke [2 ]
Mano, Toshiaki [2 ]
机构
[1] Kansai Rosai Hosp, Cardiovasc Ctr, Dept Clin Engn, 3-1-69 Inabaso, Amagasaki, Hyogo 660851, Japan
[2] Kansai Rosai Hosp, Cardiovasc Ctr, Amagasaki, Hyogo, Japan
[3] Osaka Univ, Grad Sch Med, Dept Diabet Care Med, Osaka, Japan
关键词
drug-coated balloon; endovascular therapy; femoropopliteal artery; intravascular ultrasound; restenosis; ARTERY-DISEASE;
D O I
10.1177/15266028221081082
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose: Although the size of drug-coated balloons (DCBs) is determined according to the vessel diameter during femoropopliteal (FP)-endovascular therapy (EVT), the measurements of the vessel diameter vary among modalities and its definitions. The aim of this study was to reveal whether the DCB size fitting (1) angiographically-measured lumen diameter (Angio-lumen size), (2) intravascular ultrasound (IVUS)-measured lumen diameter (IVUS-lumen size), or (3) IVUS-measured external elastic membrane (EEM) diameter (IVUS-EEM size) would be beneficial in restenosis occurrence. Materials and Methods: This retrospective, single-center study included 231 de novo FP lesions in 165 patients with peripheral artery disease treated with IN.PACT Admiral DCB under IVUS evaluation. The reference vessel diameter was evaluated as the lumen or EEM diameter at the healthy site distal to the lesion. We retrospectively determined whether the DCB size was close to (ie, equal to or different by <0.5 mm from) Angio-lumen size, IVUS-lumen size, and IVUS-EEM size. The association of the size of DCB with restenosis risk was investigated. Results: The mean lesion length was 13 +/- 9 cm and the prevalence of chronic total occlusion was 18%. During a mean follow-up period of 17 +/- 9 months, restenosis occurred in 26% of lesions. Lesions treated with a DCB of IVUS-EEM size had a lower 2 year restenosis rate than those treated with a DCB over/under IVUS-EEM size (19.7 +/- 5.7% vs 34.5 +/- 4.7%, p=0.02 by the log-rank test), while the restenosis rate was not significantly different between DCBs of Angio-lumen size or IVUS-lumen size and those over/under the size (both p>0.05). The multivariate Cox regression analysis revealed that DCBs of IVUS-EEM size were independently associated with a reduced risk of restenosis (adjusted hazard ratio 0.50; 95% confidence interval 0.27-0.95; p=0.03). Conclusion: The DCBs of IVUS-EEM size, but not of Angio-lumen size or IVUS-lumen size, were associated with a reduced risk of restenosis after FP-EVT. Determining the DCB size according to IVUS-evaluated EEM diameter would be potentially beneficial in restenosis occurrence.
引用
收藏
页码:269 / 280
页数:12
相关论文
共 50 条
  • [1] Clinical Outcomes of Repetition of Drug-Coated Balloon for Femoropopliteal Restenosis After Drug-Coated Balloon Treatment
    Jang, Shih-Jung
    Chou, Hsin-Hua
    Juang, Jyh-Ming Jimmy
    Hsieh, Chien-An
    Duan, De-Min
    Huang, Hsuan-Li
    Ko, Yu-Lin
    [J]. CIRCULATION JOURNAL, 2017, 81 (07) : 993 - 998
  • [2] Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
    Kazunori Horie
    Akiko Tanaka
    Kenji Suzuki
    Masataka Taguri
    Naoto Inoue
    [J]. CVIR Endovascular, 4
  • [3] Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
    Horie, Kazunori
    Tanaka, Akiko
    Suzuki, Kenji
    Taguri, Masataka
    Inoue, Naoto
    [J]. CVIR ENDOVASCULAR, 2021, 4 (01)
  • [4] Drug-Coated Balloon for the Treatment of Femoropopliteal Tosaka Class III In-stent Restenosis Lesions
    Zhang, Bihui
    Niu, Guochen
    Yan, Ziguang
    Zou, Yinghua
    Tong, Xiaoqiang
    Yang, Min
    [J]. FRONTIERS IN SURGERY, 2021, 7
  • [5] Debulking plus drug-coated balloon angioplasty versus drug-coated balloon angioplasty alone for femoropopliteal Tosaka III in-stent restenosis lesions
    Li, Liqiang
    Tong, Zhu
    Cui, Shijun
    Guo, Lianrui
    [J]. VIDEOSURGERY AND OTHER MINIINVASIVE TECHNIQUES, 2023, 18 (01) : 166 - 172
  • [6] Failure mode and bimodal restenosis of drug-coated balloon in femoropopliteal intervention
    Huang, Hsuan-Li
    Chou, Hsin-Hua
    Chen, I-Chih
    Hsieh, Chien-An
    Jang, Shih-Jung
    Tzeng, I-Shiang
    Ko, Yu-Lin
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 259 : 170 - 177
  • [7] Factors Associated With Early and Late Restenosis Following Drug-Coated Balloon Treatment for Patients With Femoropopliteal Lesions
    Toyoshima, Taku
    Iida, Osamu
    Takahara, Mitsuyoshi
    Okamoto, Shin
    Ishihara, Takayuki
    Nanto, Kiyonori
    Tsujimura, Takuya
    Hata, Yosuke
    Higashino, Naoko
    Nakao, Sho
    Tsukizawa, Tomofumi
    Nishian, Kunihiko
    Fujihara, Masahiko
    Kawasaki, Daizo
    Mano, Toshiaki
    [J]. JOURNAL OF ENDOVASCULAR THERAPY, 2023,
  • [8] Factors Associated With Early and Late Restenosis Following Drug-Coated Balloon Treatment for Patients in Femoropopliteal Lesions
    Toyoshima, Taku
    Iida, Osamu
    Asai, Mitsutoshi
    Masuda, Masaharu
    Okamoto, Shin
    Ishihara, Takayuki
    Nanto, Kiyonori
    Tsujimura, Takuya
    Matsuda, Yasuhiro
    Hata, Yosuke
    Uematsu, Hiroyuki
    Higashino, Naoko
    Nakao, Sho
    Tsukizawa, Tomofumi
    Fujihara, Masahiko
    Nishian, Kunihiko
    Kawasaki, Daizo
    Takahara, Mitsuyoshi
    Mano, Toshiaki
    [J]. CIRCULATION, 2022, 146
  • [9] Neutrophil-to-Lymphocyte Ratio Predicts Restenosis After Drug-Coated Balloon Therapy for Femoropopliteal Artery Lesions: A Retrospective Study
    Wang, Zhihong
    Sheng, Lei
    Gu, Hongbin
    Yang, Fan
    Xie, Huajie
    Li, Mingfei
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [10] Safety and efficacy of paclitaxel drug-coated balloon in femoropopliteal in-stent restenosis
    Anantha-Narayanan, Mahesh
    Love, Keith
    Nagpal, Sameer
    Sheikh, Azfar Bilal
    Regan, Christopher J.
    Mena-Hurtado, Carlos
    [J]. EXPERT REVIEW OF MEDICAL DEVICES, 2020, 17 (06) : 533 - 539